Influence of serum and albumins from different species on stability of camptothecin-loaded micelles.

[1]  R. Hertzberg,et al.  On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex. , 1989, Biochemistry.

[2]  T. Okano,et al.  Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. , 1991, Cancer research.

[3]  V. Stella,et al.  A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues. , 1992, Journal of pharmaceutical sciences.

[4]  E K Rowinsky,et al.  The current status of camptothecin analogues as antitumor agents. , 1993, Journal of the National Cancer Institute.

[5]  G. Kwon,et al.  Influencing factors on in vitro micelle stability of adriamycin-block copolymer conjugates , 1994 .

[6]  T. Burke,et al.  Differential interactions of camptothecin lactone and carboxylate forms with human blood components. , 1994, Biochemistry.

[7]  T. Burke,et al.  Marked interspecies variations concerning the interactions of camptothecin with serum albumins: a frequency-domain fluorescence spectroscopic study. , 1994, Biochemistry.

[8]  I. Nabiev,et al.  Interactions of lactone, carboxylate and self‐aggregated forms of camptothecin with human and bovine serum albumins , 1997, FEBS letters.

[9]  M. Manfait,et al.  Kinetics of lactone hydrolysis in antitumor drugs of camptothecin series as studied by fluorescence spectroscopy. , 1998, Biochimica et biophysica acta.

[10]  T. Okano,et al.  Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[11]  Y. Pommier,et al.  Spectroscopic and biochemical characterisation of self-aggregates formed by antitumor drugs of the camptothecin family: their possible role in the unique mode of drug action. , 1998, Biochemical pharmacology.

[12]  T. Okano,et al.  Selective delivery of adriamycin to a solid tumor using a polymeric micelle carrier system. , 1999, Journal of drug targeting.

[13]  B. Giovanella,et al.  Dependence of Anticancer Activity of Camptothecins on Maintaining Their Lactone Function , 2000, Annals of the New York Academy of Sciences.

[14]  B. Baguley,et al.  Effects of protein binding on the in vitro activity of antitumour acridine derivatives and related anticancer drugs , 2000, Cancer Chemotherapy and Pharmacology.

[15]  G. Kwon,et al.  Micelles self-assembled from poly(ethylene oxide)-block-poly(N-hexyl stearate L-aspartamide) by a solvent evaporation method: effect on the solubilization and haemolytic activity of amphotericin B. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[16]  T. Okano,et al.  Incorporation of the Anticancer Agent KRN5500 into Polymeric Micelles Diminishes the Pulmonary Toxicity , 2002, Japanese journal of cancer research : Gann.

[17]  Mitsuru Hashida,et al.  Factors affecting drug and gene delivery: effects of interaction with blood components. , 2002, Critical reviews in therapeutic drug carrier systems.

[18]  H. Maeda,et al.  Macromolecular Therapeutics , 2003, Clinical pharmacokinetics.

[19]  Teruo Okano,et al.  Analysis of Micelle Formation of an Adriamycin-Conjugated Poly(Ethylene Glycol)–Poly(Aspartic Acid) Block Copolymer by Gel Permeation Chromatography , 1993, Pharmaceutical Research.

[20]  T. Okano,et al.  Polymer Design and Incorporation Methods for Polymeric Micelle Carrier System Containing Water-insoluble Anti-cancer Agent Camptothecin , 2004, Journal of drug targeting.

[21]  T. Burke,et al.  The Acidic Microclimate in Poly(lactide-co-glycolide) Microspheres Stabilizes Camptothecins , 1999, Pharmaceutical Research.

[22]  T. Okano,et al.  Block Copolymer Design for Camptothecin Incorporation into Polymeric Micelles for Passive Tumor Targeting , 2004, Pharmaceutical Research.